Marlowe C K, Selassie C D, Santi D V
COR Therapeutics Inc., San Francisco, California 94080.
J Med Chem. 1995 Mar 17;38(6):967-72. doi: 10.1021/jm00006a016.
The inhibitory activities of 60 4,6-diamino-1,2-dihydro-2,2-dimethyl-1- (X-phenyl)-s-triazines versus purified, recombinant Pneumocystis carinii (Pc) dihydrofolate reductase (DHFR) have been determined at pH 7.0. Utilization of these Kiapp values has led to the formulation of appropriate quantitative structure-activity relationships (QSAR's) for both meta- and parasubstituted derivatives. The QSAR's from Pc are compared with other triazine QSAR's derived versus chicken, murine tumor, Escherichia coli, and particularly human DHFR. Selectivity indices indicate that hydrophobic triazines are particularly effective versus Pc DHFR; they have lower Ki values for Pc DHFR than for human DHFR.
已在pH 7.0条件下测定了60种4,6 - 二氨基 - 1,2 - 二氢 - 2,2 - 二甲基 - 1 -(X - 苯基)- s - 三嗪对纯化的重组卡氏肺孢子虫(Pc)二氢叶酸还原酶(DHFR)的抑制活性。利用这些表观抑制常数(Kiapp)值,已为间位和对位取代衍生物建立了合适的定量构效关系(QSAR)。将来自Pc的QSAR与针对鸡、鼠肿瘤、大肠杆菌,特别是人DHFR得出的其他三嗪QSAR进行了比较。选择性指数表明,疏水性三嗪对Pc DHFR特别有效;它们对Pc DHFR的Ki值低于对人DHFR的Ki值。